Company news

Niagen Bioscience, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ChromaDex to Report First Quarter 2020 Financial Results on Monday, May 11, 2020

April 30, 2020

Cellular Health Market Leader Tru Niagen® to Launch in U.K. Online and in Retail Stores Exclusively with Superdrug, Expanding Global Retail Partnership Between ChromaDex and A.S. Watson Group

April 27, 2020

ChromaDex Commits to COVID-19 Research Following Promising Initial Preclinical Findings Showing Viral Infections Deplete NAD and SARS-CoV-2-Infected Cells Activate NAD Defense Pathway That Utilizes Nicotinamide Riboside (NR)

April 19, 2020

Elysium Health, Inc. Loses Appeal of Patent Challenge Decision, Upholding Validity of ChromaDex Intellectual Property

April 13, 2020

Cellular Health Market Leader Tru Niagen® Launches Online in Australia

March 22, 2020

ChromaDex corporation reports 2019 financial results

March 9, 2020

New Niagen® Nicotinamide Riboside (NR) Study Deepens Understanding of NAD Decline and Hearing Loss in Animal Model

February 26, 2020

ChromaDex to Report Fourth Quarter 2019 Financial Results on Tuesday, March 10, 2020

February 24, 2020

ChromaDex Partners with Personalized Nutrition Company, Persona Nutrition, Expanding Global Partnership with Nestlé Health Science

February 11, 2020

ChromaDex Launches New Line of High Purity Cannabinoid (CBD) Reference Standards Available for Research and Analytical Testing Worldwide

February 2, 2020

ChromaDex Achieves New Regulatory Milestones in the European Union & Australia

January 14, 2020

← Newer news releases

Calls

The 5 newest of 31 calls. Every call is listed under its year.

Decks

The 5 newest of 60 decks. Every deck is listed under its year.